Cargando…

Phosphodiesterase 9A in Brain Regulates cGMP Signaling Independent of Nitric-Oxide

PDE9A is a cGMP-specific phosphodiesterase expressed in neurons throughout the brain that has attracted attention as a therapeutic target to treat cognitive disorders. Indeed, PDE9A inhibitors are under evaluation in clinical trials as a treatment for Alzheimer’s disease and schizophrenia. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Harms, John F., Menniti, Frank S., Schmidt, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716477/
https://www.ncbi.nlm.nih.gov/pubmed/31507355
http://dx.doi.org/10.3389/fnins.2019.00837